Please note, this OEL/ADE monograph also applies to oliceridine hydrochloride (CAS RN 1401031-39-7) and oliceridine fumarate (CAS RN 1467617-09-9). Oliceridine, formerly known as TRV130, is a biased opioid agonist with analgesic effects. Oliceridine is indicated in adults for the management of acute pain severe enough to require intravenous (IV) opioid analgesics and for whom no acceptable alternative treatments exist. Oliceridine is a United States (US) Drug Enforcement Administration (DEA) Schedule II controlled substance. Oliceridine was available as an injection solution for IV administration.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Oliceridine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.